Inventaire - dine venner og fællesskaber er dit bedste bibliotek - Inventaire

Targeting cell entry of enveloped viruses as an antiviral strategy.

udgivet i: Molecules

dato for udgivelse: 2010-12-30

sprog: engelsk

main subject: anti-HIV agents

Cites articles 125

Date

Titel

Forfattere

2011-01-25

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

François-Loïc Cosset, Giorgia Zandomeneghi, Dimitri Lavillette, Antoine Loquet, Beat H Meier, Anja Böckmann
2010-05-15

Viral proteins function as ion channels

Kai Wang, Shiqi Xie
2010-02-13

A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry

Rumin Zhang
2010-03-15

Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy.

Thomas Berg
2010-06-01

Multiple effects of silymarin on the hepatitis C virus lifecycle

Jane A. McKeating, Volker Lohmann, David M. Owen, Joe Grove, Tyler N. Graf, Yaakov Nahmias, Nicholas H. Oberlies
2010-01-05

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein
2010-09-21

Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein

Takashi Suzuki, Masataka Arihara
2010-06-02

Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes

Fei Xiao, Christopher J. Mee, Jane A. McKeating, Catherine Schuster, Thomas F Baumert, Samira Fafi-Kremer, Eric Soulier, Patrick Pessaux
2010-09-07

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

Che C Colpitts, Alexey Ustinov, Richard M. Epand
2010-05-06

Influenza M2 proton channels

James J Chou
2010-02-24

Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin

Evelien Vanderlinden, Lieve Naesens
2010-08-01

Mechanisms of viral entry: sneaking in the front door

Jane A. McKeating
2010-04-08

Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate

Stephen C. Harrison
2010-04-01

Development of novel therapies for hepatitis C.

Jane A. McKeating, David N. Frick
2010-06-02

Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion
2010-09-15

Actinohivin: specific amino acid residues essential for anti-HIV activity

Satoshi Ōmura
2010-02-19

The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule

Patrick England, Annette Martin, Felix Rey
2010-05-01

Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody

Michael Saag, Yakov Rotshteyn, Nancy Stambler
2010-03-31

Viral entry inhibitors targeted to the membrane site of action

Bruce A. Mungall, Mohamad Aljofan, Matteo Porotto, Anne Moscona
2010-05-24

Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope

Kristel Van Laethem, Dominique Schols, Jan Balzarini
2010-03-23

HIV-1 fusion inhibitor peptides enfuvirtide and T-1249 interact with erythrocyte and lymphocyte membranes

Nuno C. Santos, Miguel A. Castanho
2010-01-01

Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses

Stefan Kunz, Giulia Pasqual
2010-03-30

Identification of hepatoprotective flavonolignans from silymarin

Tyler N. Graf, Volker Lohmann, Nicholas H. Oberlies
2010-03-10

Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida

Christian Hampp, Almut G. Winterstein
2010-03-17

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors

Hans-Dieter Klenk, Markus Eickmann, Wolfgang Garten
2010-05-13

A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells

Rachel Kaletsky, Donna Huryn, Paul Bates
2010-09-01

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

Cameron P. Simmons, Felix Rey, Michael S. Diamond, Soila Sukupolvi-Petty, Martina Beltramello, Federica Sallusto, Antonio Lanzavecchia, Paul R Young, Luca Varani, Luca Simonelli, Eva Harris, Stephen S Whitehead, Aravinda M. de Silva
2010-09-02

A novel small molecule inhibitor of hepatitis C virus entry
2010

HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity

Satoshi Ōmura, Jason P. Mooney, Nobuyuki Matoba, David C. Montefiori
2010-11-01

New perspectives in HCV therapy: entry inhibitors

Marco Donia, Massimo Libra, Guido Scalia, James A. McCubrey, Ferdinando Nicoletti, Bruno Cacopardo
2010-02-16

A broad-spectrum antiviral targeting entry of enveloped viruses

Anna N. Honko, Benhur Lee, Lisa Hensley, Alexander N. Freiberg, Matteo Porotto, Anne Moscona, Hector C Aguilar
2009-12-04

Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase

Abdelhakim Ahmed-Belkacem, Jean-Michel Pawlotsky, Ralf-Torsten Pohl

Artikel - wd:Q37824811

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere

you are offline